Fulgent Genetics (FLGT-Q)
NASDAQ:FLGT
18.88
0.16
(0.84%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Fulgent Genetics (FLGT-Q) is facing challenges in its growth trajectory as indicated by recent expert reviews. Although the company's latest quarterly earnings surpassed expectations, revenue continues to decline, indicating underlying issues. However, there are bright spots; the pharmaceutical division is developing well, boasting over 30 patents and an encouraging lead drug candidate. The strong balance sheet further supports the company's foundation. Despite these positives, experts suggest that the company may have to weather a storm before seeing improvements in its growth metrics. Overall, while there is potential, caution is warranted regarding future performance.
- «
- ‹
- 1
- ›
- »
Fulgent Genetics(FLGT-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 3
Fulgent Genetics(FLGT-Q) Frequently Asked Questions
What is Fulgent Genetics stock symbol?
Fulgent Genetics is a American stock, trading under the symbol FLGT-Q on the NASDAQ (FLGT). It is usually referred to as NASDAQ:FLGT or FLGT-Q
Is Fulgent Genetics a buy or a sell?
In the last year, 3 stock analysts published opinions about FLGT-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Fulgent Genetics.
Is Fulgent Genetics a good investment or a top pick?
Fulgent Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Fulgent Genetics.
Why is Fulgent Genetics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Fulgent Genetics worth watching?
3 stock analysts on Stockchase covered Fulgent Genetics In the last year. It is a trending stock that is worth watching.
What is Fulgent Genetics stock price?
On 2025-04-25, Fulgent Genetics (FLGT-Q) stock closed at a price of $18.88.
We have some comments posted on FLGT. While it is not without potential, it is likely going to get worse before it bets better, growth-wise. The most recent quarterly earnings were fine as revenue continued to decline, but beat estimates, along with EPS. There are positives as the pharma side of the business is making progress with over 30 issued or active patents and a promising lead drug candidate. The balance sheet does continue to be strong. We are OK selling.
Unlock Premium - Try 5i Free